omega-n-methylarginine has been researched along with hydrochlorothiazide in 1 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (hydrochlorothiazide) | Trials (hydrochlorothiazide) | Recent Studies (post-2010) (hydrochlorothiazide) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 6,921 | 2,165 | 1,262 |
| Protein | Taxonomy | omega-n-methylarginine (IC50) | hydrochlorothiazide (IC50) |
|---|---|---|---|
| Carbonic anhydrase 2 | Homo sapiens (human) | 5.4954 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Handrock, R; Jacobi, J; John, S; Klingbeil, AU; Schmieder, RE; Schneider, MP | 1 |
1 trial(s) available for omega-n-methylarginine and hydrochlorothiazide
| Article | Year |
|---|---|
Effect of AT1 receptor blockade on endothelial function in essential hypertension.
Topics: Acetylcholine; Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Blood Pressure; Cohort Studies; Diuretics; Double-Blind Method; Endothelium, Vascular; Enzyme Inhibitors; Female; Forearm; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; omega-N-Methylarginine; Receptor, Angiotensin, Type 1; Regional Blood Flow; Rest; Sodium Chloride Symporter Inhibitors; Tetrazoles; Valine; Valsartan; Vasodilator Agents | 2003 |